Cargando…

Editorial: Toxic Plant Proteins as Experimental Drugs for Human Pathologies

Detalles Bibliográficos
Autores principales:	Polito, Letizia, Bortolotti, Massimo, Iglesias, Rosario, Bolognesi, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113869/ https://www.ncbi.nlm.nih.gov/pubmed/33995114 http://dx.doi.org/10.3389/fphar.2021.689924

Ejemplares similares

Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering?
por: Zanello, Andrea, et al.
Publicado: (2022)

Kirkiin: A New Toxic Type 2 Ribosome-Inactivating Protein from the Caudex of Adenia kirkii
por: Bortolotti, Massimo, et al.
Publicado: (2021)

Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling
por: Mercatelli, Daniele, et al.
Publicado: (2020)

Primary Sequence and 3D Structure Prediction of the Plant Toxin Stenodactylin
por: Iglesias, Rosario, et al.
Publicado: (2020)

Editorial: Methods and application in experimental pharmacology and drug discovery: 2021
por: Polito, Letizia, et al.
Publicado: (2022)

Hyperuricaemia, Xanthine Oxidoreductase and Ribosome-Inactivating Proteins from Plants: The Contributions of Fiorenzo Stirpe to Frontline Research
por: Bolognesi, Andrea, et al.
Publicado: (2017)

Plants Producing Ribosome-Inactivating Proteins in Traditional Medicine
por: Polito, Letizia, et al.
Publicado: (2016)

Ribosome-Inactivating Proteins from Plants: A Historical Overview
por: Bolognesi, Andrea, et al.
Publicado: (2016)

Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects
por: Battelli, Maria Giulia, et al.
Publicado: (2016)

Momordica charantia, a Nutraceutical Approach for Inflammatory Related Diseases
por: Bortolotti, Massimo, et al.
Publicado: (2019)

Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a  Detoxifying Enzyme
por: Battelli, Maria Giulia, et al.
Publicado: (2016)

Ricin: An Ancient Story for a Timeless Plant Toxin
por: Polito, Letizia, et al.
Publicado: (2019)

Bouganin, an Attractive Weapon for Immunotoxins
por: Bortolotti, Massimo, et al.
Publicado: (2018)

Toxin and Immunotoxin Based Therapeutic Approaches
por: Bortolotti, Massimo, et al.
Publicado: (2022)

Protein Synthesis Inhibition Activity by Strawberry Tissue Protein Extracts during Plant Life Cycle and under Biotic and Abiotic Stresses
por: Polito, Letizia, et al.
Publicado: (2013)

Sequence, Structure, and Binding Site Analysis of Kirkiin in Comparison with Ricin and Other Type 2 RIPs
por: Maiello, Stefania, et al.
Publicado: (2021)

Immunotoxins and Other Conjugates Containing Saporin-S6 for Cancer Therapy
por: Polito, Letizia, et al.
Publicado: (2011)

Xanthine oxidoreductase in cancer: more than a differentiation marker
por: Battelli, Maria Giulia, et al.
Publicado: (2015)

High in Vitro Anti-Tumor Efficacy of Dimeric Rituximab/Saporin-S6 Immunotoxin
por: Bortolotti, Massimo, et al.
Publicado: (2016)

Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase
por: Battelli, Maria Giulia, et al.
Publicado: (2018)

Pro-Aging Effects of Xanthine Oxidoreductase Products
por: Battelli, Maria Giulia, et al.
Publicado: (2020)

Xanthine oxidoreductase: A leading actor in cardiovascular disease drama
por: Polito, Letizia, et al.
Publicado: (2021)

Xanthine oxidoreductase: One enzyme for multiple physiological tasks
por: Bortolotti, Massimo, et al.
Publicado: (2021)

New Insights on Saporin Resistance to Chemical Derivatization with Heterobifunctional Reagents
por: Bortolotti, Massimo, et al.
Publicado: (2023)

Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview
por: Polito, Letizia, et al.
Publicado: (2016)

Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives
por: Mercatelli, Daniele, et al.
Publicado: (2018)

Saporin-S6: A Useful Tool in Cancer Therapy
por: Polito, Letizia, et al.
Publicado: (2013)

Editorial: Advancements in computational studies of drug toxicity
por: Flynn, Noah R., et al.
Publicado: (2023)

Survival and death of intestinal cells infected by Chlamydia trachomatis
por: Foschi, Claudio, et al.
Publicado: (2019)

Antibody Conjugates for Sarcoma Therapy: How Far along Are We?
por: Polito, Letizia, et al.
Publicado: (2021)

Editorial: Peptidyl-Prolyl Isomerases in Human Pathologies
por: Tuccinardi, Tiziano, et al.
Publicado: (2019)

Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021
por: Trostchansky, Andres, et al.
Publicado: (2022)

Editorial: Women in experimental pharmacology and drug discovery: 2021
por: Rižner, Tea Lanišnik, et al.
Publicado: (2022)

Editorial: Insights in experimental pharmacology and drug discovery: 2022
por: Latini, Alexandra, et al.
Publicado: (2023)

Editorial: Pharmacological interaction between drugs and medicinal plants
por: Déciga-Campos, Myrna, et al.
Publicado: (2022)

Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells
por: Polito, Letizia, et al.
Publicado: (2017)

Editorial: Model organisms in experimental pharmacology and drug discovery 2022
por: Nainu, Firzan, et al.
Publicado: (2023)

Editorial: Spotlight on artificial intelligence in experimental pharmacology and drug discovery
por: Schöning, Verena, et al.
Publicado: (2023)

Editorial: Toxicity Mechanisms, Exposure, Toxicokinetic and Risk Assessment Aspects of Metals, Toxic for Animals and Humans
por: Zhu, Yanzhu, et al.
Publicado: (2022)

Editorial: Brief research reports in experimental pharmacology and drug discovery: 2022
por: Hassan, Tahsin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tgtlrbk599lhfjjgt39ik5iiuk